カテゴリ： 世界, 消費財/食品, QYResearch

麻薬の世界市場2023年：ファストスリープニュー、保定寧混合物、ルミアンバオ、その他複合麻酔薬

■ 英語タイトル：Global Narcotic Drugs Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8825）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8825
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[麻薬の世界市場2023年：ファストスリープニュー、保定寧混合物、ルミアンバオ、その他複合麻酔薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料は麻薬のグローバル市場について調査・分析し、世界の麻薬市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（ファストスリープニュー、保定寧混合物、ルミアンバオ、その他複合麻酔薬）、用途別セグメント分析（病院、クリニック）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、AstraZeneca、MPAPHARMA、Johnson & Johnson、Roche、LGC Group、Hikma Pharmaceuticals、Baxter、Maruishi、AuroMedics、Piramal Healthcare、ABbVie、Dechraなどが含まれています。麻薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、麻薬市場規模を算出する際に考慮しました。

・麻薬市場の概要
- 製品の定義
- 麻薬の種類別セグメント
- 世界の麻薬市場規模：タイプ別分析（ファストスリープニュー、保定寧混合物、ルミアンバオ、その他複合麻酔薬）
- 麻薬の用途別セグメント
- 世界の麻薬市場規模：用途別分析（病院、クリニック）
- 世界の麻薬市場規模予測（2018年-2029年）
- 麻薬の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 麻薬市場の競争状況およびトレンド

・麻薬の地域別市場規模
- 北米の麻薬市場規模（2018年-2029年）
- 米国の麻薬市場規模（2018年-2029年）
- ヨーロッパの麻薬市場規模（2018年-2029年）
- アジア太平洋の麻薬市場規模（2018年-2029年）
- 中国の麻薬市場規模（2018年-2029年）
- 日本の麻薬市場規模（2018年-2029年）
- 韓国の麻薬市場規模（2018年-2029年）
- インドの麻薬市場規模（2018年-2029年）
- オーストラリアの麻薬市場規模（2018年-2029年）
- 中南米の麻薬市場規模（2018年-2029年）
- 中東・アフリカの麻薬市場規模（2018年-2029年）

・種類別セグメント：ファストスリープニュー、保定寧混合物、ルミアンバオ、その他複合麻酔薬
- 世界の麻薬のタイプ別販売量（2018年-2023年）
- 世界の麻薬のタイプ別売上（2018年-2023年）
- 世界の麻薬のタイプ別価格

・用途別セグメント：病院、クリニック
- 世界の麻薬の用途別販売量（2018年-2023年）
- 世界の麻薬の用途別売上（2018年-2023年）
- 世界の麻薬の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
AstraZeneca、MPAPHARMA、Johnson & Johnson、Roche、LGC Group、Hikma Pharmaceuticals、Baxter、Maruishi、AuroMedics、Piramal Healthcare、ABbVie、Dechra

・産業チェーンと販売チャネルの分析
- 麻薬産業チェーン分析
- 麻薬の主要原材料
- 麻薬の販売チャネル
- 麻薬のディストリビューター
- 麻薬の主要顧客

・麻薬市場ダイナミクス
- 麻薬の業界動向
- 麻薬市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Narcotic Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Narcotic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Narcotic Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Narcotic Drugs include AstraZeneca, MPAPHARMA, Johnson & Johnson, Roche, LGC Group, Hikma Pharmaceuticals, Baxter, Maruishi and AuroMedics, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Narcotic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Narcotic Drugs.
The Narcotic Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Narcotic Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Narcotic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
AstraZeneca
MPAPHARMA
Johnson & Johnson
Roche
LGC Group
Hikma Pharmaceuticals
Baxter
Maruishi
AuroMedics
Piramal Healthcare
ABbVie
Dechra
Segment by Type
Fast Sleep New
Baodingning Mixture
Lumianbao
Other Compound Anesthetics
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Narcotic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Narcotic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Narcotic Drugs Market Overview
1.1 Product Overview and Scope of Narcotic Drugs
1.2 Narcotic Drugs Segment by Type
1.2.1 Global Narcotic Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Fast Sleep New
1.2.3 Baodingning Mixture
1.2.4 Lumianbao
1.2.5 Other Compound Anesthetics
1.3 Narcotic Drugs Segment by Application
1.3.1 Global Narcotic Drugs Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Narcotic Drugs Market Size Estimates and Forecasts
1.4.1 Global Narcotic Drugs Revenue 2018-2029
1.4.2 Global Narcotic Drugs Sales 2018-2029
1.4.3 Global Narcotic Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Narcotic Drugs Market Competition by Manufacturers
2.1 Global Narcotic Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Narcotic Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Narcotic Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Narcotic Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Narcotic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Narcotic Drugs, Product Type & Application
2.7 Narcotic Drugs Market Competitive Situation and Trends
2.7.1 Narcotic Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Narcotic Drugs Players Market Share by Revenue
2.7.3 Global Narcotic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Narcotic Drugs Retrospective Market Scenario by Region
3.1 Global Narcotic Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Narcotic Drugs Global Narcotic Drugs Sales by Region: 2018-2029
3.2.1 Global Narcotic Drugs Sales by Region: 2018-2023
3.2.2 Global Narcotic Drugs Sales by Region: 2024-2029
3.3 Global Narcotic Drugs Global Narcotic Drugs Revenue by Region: 2018-2029
3.3.1 Global Narcotic Drugs Revenue by Region: 2018-2023
3.3.2 Global Narcotic Drugs Revenue by Region: 2024-2029
3.4 North America Narcotic Drugs Market Facts & Figures by Country
3.4.1 North America Narcotic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Narcotic Drugs Sales by Country (2018-2029)
3.4.3 North America Narcotic Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Narcotic Drugs Market Facts & Figures by Country
3.5.1 Europe Narcotic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Narcotic Drugs Sales by Country (2018-2029)
3.5.3 Europe Narcotic Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Narcotic Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Narcotic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Narcotic Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Narcotic Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Narcotic Drugs Market Facts & Figures by Country
3.7.1 Latin America Narcotic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Narcotic Drugs Sales by Country (2018-2029)
3.7.3 Latin America Narcotic Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Narcotic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Narcotic Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Narcotic Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Narcotic Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Narcotic Drugs Sales by Type (2018-2029)
4.1.1 Global Narcotic Drugs Sales by Type (2018-2023)
4.1.2 Global Narcotic Drugs Sales by Type (2024-2029)
4.1.3 Global Narcotic Drugs Sales Market Share by Type (2018-2029)
4.2 Global Narcotic Drugs Revenue by Type (2018-2029)
4.2.1 Global Narcotic Drugs Revenue by Type (2018-2023)
4.2.2 Global Narcotic Drugs Revenue by Type (2024-2029)
4.2.3 Global Narcotic Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Narcotic Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Narcotic Drugs Sales by Application (2018-2029)
5.1.1 Global Narcotic Drugs Sales by Application (2018-2023)
5.1.2 Global Narcotic Drugs Sales by Application (2024-2029)
5.1.3 Global Narcotic Drugs Sales Market Share by Application (2018-2029)
5.2 Global Narcotic Drugs Revenue by Application (2018-2029)
5.2.1 Global Narcotic Drugs Revenue by Application (2018-2023)
5.2.2 Global Narcotic Drugs Revenue by Application (2024-2029)
5.2.3 Global Narcotic Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Narcotic Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 AstraZeneca Narcotic Drugs Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 MPAPHARMA
6.2.1 MPAPHARMA Corporation Information
6.2.2 MPAPHARMA Description and Business Overview
6.2.3 MPAPHARMA Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 MPAPHARMA Narcotic Drugs Product Portfolio
6.2.5 MPAPHARMA Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson & Johnson Narcotic Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Roche Narcotic Drugs Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 LGC Group
6.5.1 LGC Group Corporation Information
6.5.2 LGC Group Description and Business Overview
6.5.3 LGC Group Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 LGC Group Narcotic Drugs Product Portfolio
6.5.5 LGC Group Recent Developments/Updates
6.6 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hikma Pharmaceuticals Narcotic Drugs Product Portfolio
6.6.5 Hikma Pharmaceuticals Recent Developments/Updates
6.7 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Baxter Narcotic Drugs Product Portfolio
6.7.5 Baxter Recent Developments/Updates
6.8 Maruishi
6.8.1 Maruishi Corporation Information
6.8.2 Maruishi Description and Business Overview
6.8.3 Maruishi Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Maruishi Narcotic Drugs Product Portfolio
6.8.5 Maruishi Recent Developments/Updates
6.9 AuroMedics
6.9.1 AuroMedics Corporation Information
6.9.2 AuroMedics Description and Business Overview
6.9.3 AuroMedics Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 AuroMedics Narcotic Drugs Product Portfolio
6.9.5 AuroMedics Recent Developments/Updates
6.10 Piramal Healthcare
6.10.1 Piramal Healthcare Corporation Information
6.10.2 Piramal Healthcare Description and Business Overview
6.10.3 Piramal Healthcare Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Piramal Healthcare Narcotic Drugs Product Portfolio
6.10.5 Piramal Healthcare Recent Developments/Updates
6.11 ABbVie
6.11.1 ABbVie Corporation Information
6.11.2 ABbVie Narcotic Drugs Description and Business Overview
6.11.3 ABbVie Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ABbVie Narcotic Drugs Product Portfolio
6.11.5 ABbVie Recent Developments/Updates
6.12 Dechra
6.12.1 Dechra Corporation Information
6.12.2 Dechra Narcotic Drugs Description and Business Overview
6.12.3 Dechra Narcotic Drugs Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Dechra Narcotic Drugs Product Portfolio
6.12.5 Dechra Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Narcotic Drugs Industry Chain Analysis
7.2 Narcotic Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Narcotic Drugs Production Mode & Process
7.4 Narcotic Drugs Sales and Marketing
7.4.1 Narcotic Drugs Sales Channels
7.4.2 Narcotic Drugs Distributors
7.5 Narcotic Drugs Customers
8 Narcotic Drugs Market Dynamics
8.1 Narcotic Drugs Industry Trends
8.2 Narcotic Drugs Market Drivers
8.3 Narcotic Drugs Market Challenges
8.4 Narcotic Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Narcotic Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Narcotic Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Narcotic Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Narcotic Drugs Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Narcotic Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Narcotic Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Narcotic Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Narcotic Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Narcotic Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Narcotic Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Narcotic Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Narcotic Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Narcotic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Narcotic Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Narcotic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Narcotic Drugs Sales by Region (2018-2023) & (Units)
Table 18. Global Narcotic Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Narcotic Drugs Sales by Region (2024-2029) & (Units)
Table 20. Global Narcotic Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Narcotic Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Narcotic Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Narcotic Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Narcotic Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Narcotic Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Narcotic Drugs Sales by Country (2018-2023) & (Units)
Table 27. North America Narcotic Drugs Sales by Country (2024-2029) & (Units)
Table 28. North America Narcotic Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Narcotic Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Narcotic Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Narcotic Drugs Sales by Country (2018-2023) & (Units)
Table 32. Europe Narcotic Drugs Sales by Country (2024-2029) & (Units)
Table 33. Europe Narcotic Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Narcotic Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Narcotic Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Narcotic Drugs Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Narcotic Drugs Sales by Region (2024-2029) & (Units)
Table 38. Asia Pacific Narcotic Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Narcotic Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Narcotic Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Narcotic Drugs Sales by Country (2018-2023) & (Units)
Table 42. Latin America Narcotic Drugs Sales by Country (2024-2029) & (Units)
Table 43. Latin America Narcotic Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Narcotic Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Narcotic Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Narcotic Drugs Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Narcotic Drugs Sales by Country (2024-2029) & (Units)
Table 48. Middle East & Africa Narcotic Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Narcotic Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Narcotic Drugs Sales (Units) by Type (2018-2023)
Table 51. Global Narcotic Drugs Sales (Units) by Type (2024-2029)
Table 52. Global Narcotic Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Narcotic Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Narcotic Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Narcotic Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Narcotic Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Narcotic Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Narcotic Drugs Price (US$/Unit) by Type (2018-2023)
Table 59. Global Narcotic Drugs Price (US$/Unit) by Type (2024-2029)
Table 60. Global Narcotic Drugs Sales (Units) by Application (2018-2023)
Table 61. Global Narcotic Drugs Sales (Units) by Application (2024-2029)
Table 62. Global Narcotic Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Narcotic Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Narcotic Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Narcotic Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Narcotic Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Narcotic Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Narcotic Drugs Price (US$/Unit) by Application (2018-2023)
Table 69. Global Narcotic Drugs Price (US$/Unit) by Application (2024-2029)
Table 70. AstraZeneca Corporation Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. AstraZeneca Narcotic Drugs Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. MPAPHARMA Corporation Information
Table 76. MPAPHARMA Description and Business Overview
Table 77. MPAPHARMA Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. MPAPHARMA Narcotic Drugs Product
Table 79. MPAPHARMA Recent Developments/Updates
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Johnson & Johnson Narcotic Drugs Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Roche Corporation Information
Table 86. Roche Description and Business Overview
Table 87. Roche Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Roche Narcotic Drugs Product
Table 89. Roche Recent Developments/Updates
Table 90. LGC Group Corporation Information
Table 91. LGC Group Description and Business Overview
Table 92. LGC Group Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. LGC Group Narcotic Drugs Product
Table 94. LGC Group Recent Developments/Updates
Table 95. Hikma Pharmaceuticals Corporation Information
Table 96. Hikma Pharmaceuticals Description and Business Overview
Table 97. Hikma Pharmaceuticals Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Hikma Pharmaceuticals Narcotic Drugs Product
Table 99. Hikma Pharmaceuticals Recent Developments/Updates
Table 100. Baxter Corporation Information
Table 101. Baxter Description and Business Overview
Table 102. Baxter Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Baxter Narcotic Drugs Product
Table 104. Baxter Recent Developments/Updates
Table 105. Maruishi Corporation Information
Table 106. Maruishi Description and Business Overview
Table 107. Maruishi Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Maruishi Narcotic Drugs Product
Table 109. Maruishi Recent Developments/Updates
Table 110. AuroMedics Corporation Information
Table 111. AuroMedics Description and Business Overview
Table 112. AuroMedics Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. AuroMedics Narcotic Drugs Product
Table 114. AuroMedics Recent Developments/Updates
Table 115. Piramal Healthcare Corporation Information
Table 116. Piramal Healthcare Description and Business Overview
Table 117. Piramal Healthcare Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Piramal Healthcare Narcotic Drugs Product
Table 119. Piramal Healthcare Recent Developments/Updates
Table 120. ABbVie Corporation Information
Table 121. ABbVie Description and Business Overview
Table 122. ABbVie Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. ABbVie Narcotic Drugs Product
Table 124. ABbVie Recent Developments/Updates
Table 125. Dechra Corporation Information
Table 126. Dechra Description and Business Overview
Table 127. Dechra Narcotic Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Dechra Narcotic Drugs Product
Table 129. Dechra Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Narcotic Drugs Distributors List
Table 133. Narcotic Drugs Customers List
Table 134. Narcotic Drugs Market Trends
Table 135. Narcotic Drugs Market Drivers
Table 136. Narcotic Drugs Market Challenges
Table 137. Narcotic Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Narcotic Drugs
Figure 2. Global Narcotic Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Narcotic Drugs Market Share by Type in 2022 & 2029
Figure 4. Fast Sleep New Product Picture
Figure 5. Baodingning Mixture Product Picture
Figure 6. Lumianbao Product Picture
Figure 7. Other Compound Anesthetics Product Picture
Figure 8. Global Narcotic Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Narcotic Drugs Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Global Narcotic Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Narcotic Drugs Market Size (2018-2029) & (US$ Million)
Figure 14. Global Narcotic Drugs Sales (2018-2029) & (Units)
Figure 15. Global Narcotic Drugs Average Price (US$/Unit) & (2018-2029)
Figure 16. Narcotic Drugs Report Years Considered
Figure 17. Narcotic Drugs Sales Share by Manufacturers in 2022
Figure 18. Global Narcotic Drugs Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Narcotic Drugs Players: Market Share by Revenue in 2022
Figure 20. Narcotic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Narcotic Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Narcotic Drugs Sales Market Share by Country (2018-2029)
Figure 23. North America Narcotic Drugs Revenue Market Share by Country (2018-2029)
Figure 24. United States Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Narcotic Drugs Sales Market Share by Country (2018-2029)
Figure 27. Europe Narcotic Drugs Revenue Market Share by Country (2018-2029)
Figure 28. Germany Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Narcotic Drugs Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Narcotic Drugs Revenue Market Share by Region (2018-2029)
Figure 35. China Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Narcotic Drugs Sales Market Share by Country (2018-2029)
Figure 45. Latin America Narcotic Drugs Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Narcotic Drugs Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Narcotic Drugs Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Narcotic Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Narcotic Drugs by Type (2018-2029)
Figure 55. Global Revenue Market Share of Narcotic Drugs by Type (2018-2029)
Figure 56. Global Narcotic Drugs Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Narcotic Drugs by Application (2018-2029)
Figure 58. Global Revenue Market Share of Narcotic Drugs by Application (2018-2029)
Figure 59. Global Narcotic Drugs Price (US$/Unit) by Application (2018-2029)
Figure 60. Narcotic Drugs Value Chain
Figure 61. Narcotic Drugs Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • コデイン麻薬のグローバル市場展望 2023年-2029年：単一成分コデイン、複合成分医薬品
  • 婦人科介護医薬品の世界市場2023年：避妊、婦人科感染症、女性感染症、閉経後疾患、婦人科がん、子宮内膜症
  • MET阻害薬の世界市場2023年：C-Met生物学的阻害剤、低分子C-Met阻害剤、C-Metアンタゴニスト抗体、HGFアンタゴニスト抗体、クリングルバリアントアンタゴニスト
  • 世界のコデイン系麻酔剤市場2022年：市場規模予測（～2028年）
  • 循環器疾患看護薬の世界市場2023年：降圧薬、抗狭心症薬、抗凝固薬、抗高脂血症薬、抗心不全薬、抗不整脈薬
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8825 )"麻薬の世界市場2023年：ファストスリープニュー、保定寧混合物、ルミアンバオ、その他複合麻酔薬" (英文：Global Narcotic Drugs Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。